Search research articles
Contact Us
Filters
Showing results (211-220 of 248) with videos related to
Page
of 25
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
May 30, 2020
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'
Patrick Schöffski, Olivier Mir, Bernd Kasper, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 5, 2022
Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study
Marie Morfouace, Peter Horak, Simon Kreutzfeldt, et al.
Molecular Oncology
|
April 8, 2021
Genomic characterization of small cell carcinomas of the uterine cervix
Anne M Schultheis, Ino de Bruijn, Pier Selenica, et al.
Advances in Radiation Oncology
|
June 13, 2020
Impact of Adjuvant Radiation Therapy in Patients With Male Breast Cancer: A Multicenter International Analysis
Daniel Rolf, Khaled Elsayad, Mohamed A M Meheissen, et al.
Cancer Research
|
April 13, 2013
SRC signaling is crucial in the growth of synovial sarcoma cells
Sebastian Michels, Marcel Trautmann, Elisabeth Sievers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 24, 2025
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors
Helena Lanzafame, Christoph E Heilig, Eva Wardelmann, et al.
Molecular Cancer Therapeutics
|
July 17, 2019
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - TORC1/2 Inhibition as Salvage Strategy
Thomas Mühlenberg, Julia Ketzer, Michael C Heinrich, et al.
Cancer
|
April 17, 2014
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
EMBO Molecular Medicine
|
March 23, 2019
Requirement for YAP1 signaling in myxoid liposarcoma
Marcel Trautmann, Ya-Yun Cheng, Patrizia Jensen, et al.
Genes, Chromosomes & Cancer
|
April 23, 2020
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays
Martina Kirchner, Julia Glade, Ulrich Lehmann, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 248) with videos related to
Sort By:
Page
of 25
European Journal of Cancer (Oxford, England : 1990)
|
May 30, 2020
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'
Patrick Schöffski, Olivier Mir, Bernd Kasper, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 5, 2022
Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study
Marie Morfouace, Peter Horak, Simon Kreutzfeldt, et al.
Molecular Oncology
|
April 8, 2021
Genomic characterization of small cell carcinomas of the uterine cervix
Anne M Schultheis, Ino de Bruijn, Pier Selenica, et al.
Advances in Radiation Oncology
|
June 13, 2020
Impact of Adjuvant Radiation Therapy in Patients With Male Breast Cancer: A Multicenter International Analysis
Daniel Rolf, Khaled Elsayad, Mohamed A M Meheissen, et al.
Cancer Research
|
April 13, 2013
SRC signaling is crucial in the growth of synovial sarcoma cells
Sebastian Michels, Marcel Trautmann, Elisabeth Sievers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 24, 2025
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors
Helena Lanzafame, Christoph E Heilig, Eva Wardelmann, et al.
Molecular Cancer Therapeutics
|
July 17, 2019
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - TORC1/2 Inhibition as Salvage Strategy
Thomas Mühlenberg, Julia Ketzer, Michael C Heinrich, et al.
Cancer
|
April 17, 2014
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
EMBO Molecular Medicine
|
March 23, 2019
Requirement for YAP1 signaling in myxoid liposarcoma
Marcel Trautmann, Ya-Yun Cheng, Patrizia Jensen, et al.
Genes, Chromosomes & Cancer
|
April 23, 2020
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays
Martina Kirchner, Julia Glade, Ulrich Lehmann, et al.
Page
of 25